Profile picture

Doctor Shakhnoza Mukhtarova

Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)
Follow
Logo ESC

Contributor content

Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
Presentation
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction
Presentation
Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction

ESC 365 is supported by